...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Have a great Sunday, especially those of you like me that are celebrating Orthodox Easter ... As well as those of you who are also like me and mourning another Maple Leafs Game 7 exit ... Ugggh!

Sincerely,

George et al

Message: Re: Zenith AGM?
6
Dec 22, 2020 05:34PM
7
Dec 22, 2020 06:16PM
2
Dec 22, 2020 06:56PM
7
Dec 22, 2020 08:12PM
7
Dec 23, 2020 07:06AM
2
Dec 23, 2020 09:11AM
6
Dec 23, 2020 10:48AM
3
Dec 24, 2020 08:49AM
1
Dec 24, 2020 10:34AM
1
Dec 24, 2020 10:41AM
2
Dec 24, 2020 10:03PM

narmac, your insights put everything into perspective very clearly. Thanks.

It is too bad for investors that Zenith will remain an academic institution for the forseable future. There is value here that competent value creators would know how to tap into for their shareholders.

It doesn't even seem fair to those with cancers to not turn this gem into someting that, if big money was thrown at it, might get in and save lives sooner.

Best in 2021

Toinv

Share
New Message
Please login to post a reply